Contralateral prophylactic mastectomy: Predictors of significant histologic findings

Cancer

Volumn 101, Issue 9, 2004, Pages 1977-1986

  Goldflam, Katja ^a   Hunt, Kelly K ^a   Gershenwald, Jeffrey E ^a   Singletary, S Eva ^a   Mirza, Nadeem ^a   Kuerer, Henry M ^a   Babiera, Gildy V ^a   Ames, Frederick C ^a   Ross, Merrick I ^a   Feig, Barry W ^a   Sahin, Aysegul A ^a   Arun, Banu ^a   Meric Bernstam, Funda ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Breast carcinoma; Gail model; Lobular carcinoma; Prophylactic mastectomy; Risk reducing mastectomy

Indexed keywords

BREAST CANCER; CANCER PREVENTION; HUMAN; MASTECTOMY; OUTCOMES RESEARCH; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SYSTEMATIC REVIEW;

ADULT; AGED; AGED, 80 AND OVER; BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; MASTECTOMY; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK;

EID: 7044231372     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20617     Document Type: Review

References (34)

1. Kollias J, Ellis IO, Elston CW, et al. Clinical and histological predictors of contralateral breast cancer. Eur J Surg Oncol. 1999;25:584-589.
2. Gao X, Fisher SG, Emami B. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. Int J Radiat Oncol Biol Phys. 2003;56:1038-1045.
3. McDonnell SK, Schaid DJ, Myers JL, et al. Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. J Clin Oncol. 2001;19:3938-3943.
4. Anderson BO. Prophylactic surgery to reduce breast cancer risk: a brief literature review. Breast J. 2001;7:321-330.
5. Newman LA, Kuerer HM, Hung KK, et al. Prophylactic mastectomy. J Am Coll Surg. 2000;191:322-330.
6. Gershenwald JE, Hunt KK, Kroll SS, et al. Synchronous elective contralateral mastectomy and immediate bilateral breast reconstruction in women with early-stage breast cancer. Ann Surg Oncol. 1998;5:529-538.
7. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81:1879-1886.
8. Singletary SE, Kroll SS. Skin-sparing mastectomy with immediate breast reconstruction. Adv Surg. 1996;30:39-52.
9. Anderson DE, Badzioch MD. Bilaterality in familial breast cancer patients. Cancer, 1985;56:2092-2098.
10. Page DL, Dupont WD. Anatomic indicators (histologic and cytologic) of increased breast cancer risk. Breast Cancer Res Treat. 1993;28:157-166.
11. Page DL, Salhany KE, Jensen RA, et al. Subsequent breast carcinoma risk after biopsy with atypia in a breast papilloma. Cancer. 1996;78:258-266.
12. Group EBCTC. Polychemotherapy for early breast: cancer: an overview of the randomised trials. Lancet. 1998;352:930-942.
13. Group EBCTC. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet. 1998;351:1451-1467.
14. Holleb AI, Montgomery R, Farrow JH. The hazard of incomplete simple mastectomy. Surg Gynecol Obstet. 1965;121:819-822.
15. Eldar S, Meguid MM, Beatty JD. Cancer of the breast after prophylactic subcutaneous mastectomy. Am J Surg. 1984;148:692-693.
16. Hartmann LC, Schaid DJ, Woods JE, et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med. 1999;340:77-84.
17. Meijers-Heijboer H, van Geel B, van Putten WL, et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med. 2001;345:159-164.
18. Rebbeck TR, Friebel T, Lynch HT, et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 2004;22:1055-1062.
19. Peralta EA, Ellenhorn JD, Wagman LD, et al. Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer. Am J Surg. 2000;180:439-445.
20. Hamm RM, Lawler F, Scheid D. Prophylactic mastectomy in women with a high risk of breast cancer. N Engl J Med. 1999;340:1837-1838; author reply 1839.
21. Broeks A, de Witte L, Nooijen A, et al. Excess risk for contralateral breast cancer in CHEK2*1100delC germline mutation carriers. Breast Cancer Res Treat. 2004;83:91-93.
22. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319:525-532.
23. Singletary SE. A working model for the time sequence of genetic changes in breast tumorigenesis. J Am Coll Surg. 2002;194:202-216.
24. Page DL, Schuyler PA, Dupont WD, et al. Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet. 2003;361:125-129.
25. Newsham IF. The long and short of chromosome 11 in breast cancer. Am J Pathol. 1998;153:5-9.
26. Lewis FR, Mellinger JD, Hayashi A, et al. Prophylactic total gastrectomy for familial gastric cancer. Surgery. 2001;130:612-617; discussion 617-619.
27. Kulkarni S, Rademaker A, Khan S, et al. Breast cancer risk correlates with level of atypia in prophylactic mastectomy (PM) specimens [abstract]. Ann Surg Oncol. 2004;11:S94.
28. Adem C, Reynolds C, Soderberg CL, et al. Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers. Cancer. 2003;97:1-11.
29. Singletary SE. Radiofrequency ablation of breast cancer. Am Surg. 2003;69:37-40.
30. Verhoog LC, Brekelmans CT, Seynaeve C, et al. Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer. Br J Cancer. 2000;83:384-386.
31. Schrag D, Kuntz KM, Garber JE, et al. Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations. JAMA. 2000;283:617-624.
32. Seynaeve C, Meijers-Heijboer EJ, Menke M, et al. Prophylactic (bilateral) mastectomy prevents contralateral breast cancer (CBC), without positive impact on survival in BRCA mutation carriers with a previous history of unilateral breast cancer [abstract]. Breast Cancer Res Treat. 2003;82:S179.
33. Zion SM, Slezak JM, Sellers TA, et al. Reoperations after prophylactic mastectomy with or without implant reconstruction. Cancer. 2003;98:2152-2160.
34. Montgomery LL, Tran KN, Heelan MC, et al. Issues of regret in women with contralateral prophylactic mastectomies. Ann Surg Oncol. 1999;6:546-552.